Union Technology: The current production and operation are normal, without any significant matters that need to be disclosed but have not been disclosed.

United Technologies announced that the closing price of the company's stock has deviated by more than 20% for two consecutive trading days, indicating abnormal fluctuations in stock trading. Upon verification, there is no need to correct or supplement the information disclosed by the company earlier. The company currently provides customers with the high-grade intermediate of chlorfenapyr through the CDMO business model, with limited overall impact on the company. Apart from the aforementioned matters, the company has not found any undisclosed major information in recent public media reports that may or have had a significant impact on the company's stock trading price. There are no undisclosed major matters related to the company by the company, controlling shareholders, or actual controller. During the abnormal stock price fluctuations, the controlling shareholders, actual controller, and their concerted action parties have not engaged in the buying and selling of the company's stocks.